| Gene symbol | TNFRSF17 | Synonyms | BCM, BCMA, CD269, TNFRSF13A | Type of gene | protein-coding |
| Chromosome | 16 | Map location | 16p13.13 | dbXrefs | |
| Description | TNF receptor superfamily member 17 | ||||
| GTO ID | GTC1787 |
| Trial ID | NCT03288493 |
| Disease | Multiple Myeloma |
| Altered gene | BCMA |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | P-BCMA-101 |
| Generation | 2nd |
| Phase | Phase1|Phase2 |
| Recruitment status | Terminated |
| Title | P-BCMA-101 Tscm CAR-T Cells in the Treatment of Patients With Multiple Myeloma (MM) |
| Year | 2017 |
| Country | United States |
| Company sponsor | Poseida Therapeutics, Inc. |
| Other ID(s) | P-BCMA-101-001 |
| Vector information | |||||
|
|||||
| Cohort 1 | |||||||||
|
|||||||||